Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α‐conotoxin RgIA

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Neurochemistry

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1471-4159.2012.07867.xPMID 22774872PMCID PMC3433650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal structure of a Cbtx–AChBP complex reveals essential interactions between snake α‐neurotoxins and nicotinic receptors

  2013cited by this paper
• New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.

  2012cited by this paper
• Analgesic conotoxins: block and G protein‐coupled receptor modulation of N‐type (CaV2.2) calcium channels

  2012cited by this paper
• Abstract 1084: Naturally occurring variants of human α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation

  2012influential reference
• Conus Venom Peptide Pharmacology

  2012cited by this paper
• The efferent medial olivocochlear-hair cell synapse.

  2012cited by this paper
• The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.

  2011cited by this paper
• Structure-activity studies on alpha-conotoxins.

  2011cited by this paper
• Nicotinic Acetylcholine Receptor-Based Blockade: Applications of Molecular Targets for Cancer Therapy

  2011cited by this paper
• Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells.

  2011cited by this paper
• A novel mechanism of inhibition of high‐voltage activated calcium channels by α‐conotoxins contributes to relief of nerve injury‐induced neuropathic pain

  2011cited by this paper
• Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells

  2011cited by this paper
• Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.

  2011cited by this paper
• Naturally-expressed nicotinic acetylcholine receptor subtypes.

  2011cited by this paper
• Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.

  2010cited by this paper
• Synthetic α-Conotoxin Mutants as Probes for Studying Nicotinic Acetylcholine Receptors and in the Development of Novel Drug Leads

  2010cited by this paper
• Scanning Mutagenesis of α-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the α9α10 Nicotinic Acetylcholine Receptor*

  2009cited by this paper
• Diversity of vertebrate nicotinic acetylcholine receptors.

  2009cited by this paper
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

  2009cited by this paper
• Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors.

  2009cited by this paper
• Molecular modeling of the alpha9alpha10 nicotinic acetylcholine receptor subtype.

  2009cited by this paper
• Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors

  2009cited by this paper
• The three‐dimensional structure of the analgesic α‐conotoxin, RgIA

  2008cited by this paper
• Conus venoms - a rich source of peptide-based therapeutics.

  2008cited by this paper
• Subtype-selective conopeptides targeted to nicotinic receptors:Concerted discovery and biomedical applications

  2008cited by this paper
• Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.

  2008cited by this paper
• Targeting the α9α10 nicotinic acetylcholine receptor to treat severe pain

  2007cited by this paper
• Heterogeneity and complexity of native brain nicotinic receptors.

  2007cited by this paper
• Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.

  2007cited by this paper
• Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization.

  2007cited by this paper
• Toxin insights into nicotinic acetylcholine receptors.

  2006cited by this paper
• Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor.

  2006cited by this paper
• Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.

  2006influential reference
• Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit.

  2006cited by this paper
• Characterization of Nicotinic Acetylcholine Receptors That Modulate Nicotine-Evoked [3H]Norepinephrine Release from Mouse Hippocampal Synaptosomes

  2006cited by this paper
• Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors

  2006influential reference
• Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

  2006cited by this paper
• Determinants of α-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor β subunit

  2006cited by this paper
• α-RgIA: A Novel Conotoxin That Specifically and Potently Blocks the α9α10 nAChR†,‡

  2006influential reference
• Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.

  2006influential reference
• Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.

  2006cited by this paper
• alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses.

  2005cited by this paper
• A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.

  2005cited by this paper
• Nicotinic Acetylcholine Receptor Subunits and Associated Proteins in Human Sperm*

  2005cited by this paper
• Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.

  2005cited by this paper
• Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an α-conotoxin PnIA variant

  2005cited by this paper
• Biophysical and pharmacological characterization of nicotinic cholinergic receptors in rat cochlear inner hair cells

  2005cited by this paper
• Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones.

  2005cited by this paper
• α-Conotoxin BuIA, a Novel Peptide from Conus bullatus, Distinguishes among Neuronal Nicotinic Acetylcholine Receptors*

  2005cited by this paper
• A Novel α-Conotoxin, PeIA, Cloned from Conus pergrandis, Discriminates between Rat α9α10 and α7 Nicotinic Cholinergic Receptors*

  2005cited by this paper
• Crystal structure of a Cbtx–AChBP complex reveals essential interactions between snake α‐neurotoxins and nicotinic receptors

  2005cited by this paper
• Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations

  2005cited by this paper
• Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras

  2004cited by this paper
• Pharmacological properties of alpha 9 alpha 10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras.

  2004cited by this paper
• Cys-loop receptors: new twists and turns.

  2004cited by this paper
• Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat.

  2004cited by this paper
• Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes.

  2004cited by this paper
• Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors.

  2004cited by this paper
• Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.

  2004cited by this paper
• Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin.

  2004cited by this paper
• α-Conotoxin PIA Is Selective for α6 Subunit-Containing Nicotinic Acetylcholine Receptors

  2003cited by this paper
• Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors.

  2003cited by this paper
• A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit.

  2002cited by this paper
• A Novel Human Nicotinic Receptor Subunit, α10, That Confers Functionality to the α9-Subunit

  2002cited by this paper
• Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons.

  2002cited by this paper
• Coexpression of α9 and α10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons

  2002cited by this paper
• Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10).

  2001cited by this paper
• α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells

  2001cited by this paper
• Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors

  2001cited by this paper
• Molecular Cloning and Mapping of the Human Nicotinic Acetylcholine Receptor α10 (CHRNA10)

  2001cited by this paper
• Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

  2000cited by this paper
• Role of a 9 Nicotinic ACh Receptor Subunits in the Development and Function of Cochlear Efferent

  1999cited by this paper
• Identification of Residues in the Neuronal α7Acetylcholine Receptor That Confer Selectivity for Conotoxin ImI*

  1998cited by this paper
• Determinants of Specificity for α-Conotoxin MII on α3β2 Neuronal Nicotinic Receptors

  1997cited by this paper
• Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.

  1997cited by this paper
• A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*)

  1996cited by this paper
• A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.

  1996cited by this paper
• Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells

  1995cited by this paper
• α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells

  1994cited by this paper
• Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells.

  1994cited by this paper

• Conopeptides as Modulators of Pain and Inflammation in Chemotherapy-Induced Peripheral Neuropathy by Targeting α7 and α9 Nicotinic Acetylcholine Receptors

  2026cites this paper
• Discovery and Optimization of a Monodisulfide Conotoxin Defines a Potent and Selective α9α10 nAChR Blocker with Analgesic Efficacy.

  2026cites this paper
• Marine-derived bioactive compounds for neuropathic pain: pharmacology and therapeutic potential

  2025cites this paper
• Human α10 nicotinic acetylcholine receptor subunits assemble to form functional receptors

  2025cites this paper
• Dual Antagonism of α9α10 nAChR and GABAB Receptor-Coupled CaV2.2 Channels by an Analgesic αO-Conotoxin Analogue.

  2024cites this paper
• α9-Containing Nicotinic Acetylcholine Receptors Are Required for RgIA-5474 Attenuation of Chemotherapy-Induced Neuropathic Pain.

  2024cites this paper
• Nicotinic acetylcholine receptors: key targets for attenuating neurodegenerative diseases.

  2023cites this paper
• Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligands.

  2023cites this paper
• Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4].

  2023cites this paper
• α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain

  2023cites this paper
• Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins.

  2023cites this paper
• Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications

  2022cites this paper
• Conus regius-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism

  2022cites this paper
• Alkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors

  2022cites this paper
• Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy

  2022cites this paper
• Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.

  2022cites this paper
• From Crystal Structures of RgIA4 in Complex with Ac-AChBP to Molecular Determinants of Its High Potency of α9α10 nAChR

  2021cites this paper
• Marine-derived nicotinic receptor antagonist toxins: Pinnatoxins and alpha conotoxins

  2021cites this paper
• Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.

  2021cites this paper
• Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1

  2021cites this paper
• Critical Residue Properties for Potency and Selectivity of α-Conotoxin RgIA Towards α9α10 Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.

  2020cites this paper
• Behavioral Pharmacology of the Cholinergic System

  2020cites this paper
• Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.

  2020cites this paper
• Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA.

  2020cites this paper
• Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors

  2019influential citation
• d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability

  2019cites this paper
• Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes

  2019cites this paper
• New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3* Nicotinic Receptors.

  2019cites this paper
• Antibodies and venom peptides: new modalities for ion channels

  2019cites this paper
• Antibodies and venom peptides: New therapeutic modalities for ion channels

  2019cites this paper
• Animal venoms in the production of medicines

  2019cites this paper
• Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways.

  2019cites this paper
• Les cônes marins, une ressource naturelle d’antalgiques venue du fond des mers : au-delà du ziconotide ?

  2019cites this paper
• αD-Conotoxins in Species of the Eastern Pacific: The Case of Conus princeps from Mexico

  2019cites this paper
• Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.

  2019cites this paper
• Targeting Nicotinic Acetylcholine Receptors for the Treatment of Pain

  2019cites this paper
• α-Conotoxin GI triazole-peptidomimetics: potent and stable blockers of a human acetylcholine receptor

  2019cites this paper
• Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models

  2018cites this paper
• Nicotinic acetylcholine receptors in neuropathic and inflammatory pain

  2018cites this paper
• α9‐containing nicotinic acetylcholine receptors and the modulation of pain

  2018cites this paper
• α‐Conotoxins active at α3‐containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition

  2018cites this paper
• α9‐ and α7‐containing receptors mediate the pro‐proliferative effects of nicotine in the A549 adenocarcinoma cell line

  2018cites this paper
• Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails

  2018influential citation
• Species specificity of rat and human &agr;7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists

  2018influential citation
• &agr;O‐Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human &agr;9&agr;10 subtype

  2017influential citation
• Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10

  2017cites this paper
• Human native Cav1 channels in chromaffin cells: contribution to exocytosis and firing of spontaneous action potentials

  2017cites this paper
• α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.

  2017cites this paper
• RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia

  2017influential citation
• Human nicotinic receptors in chromaffin cells: characterization and pharmacology

  2017cites this paper
• Peptide therapeutics from venom: Current status and potential.

  2017cites this paper
• Structure and Biological Activity of a Turripeptide from Unedogemmula bisaya Venom.

  2017cites this paper
• Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms.

  2017cites this paper
• Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor Function

  2017influential citation
• Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor

  2017cites this paper
• Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain

  2017cites this paper
• Residues Responsible for the Selectivity of α-Conotoxins for Ac-AChBP or nAChRs

  2016cites this paper
• New quinoline derivatives as nicotinic receptor modulators.

  2016cites this paper
• Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors

  2016cites this paper
• Molecular Interaction of a-Conotoxin RgIA with the Rat a 9 a 10 Nicotinic Acetylcholine Receptor s

  2016influential citation
• 6-Bromohypaphorine from Marine Nudibranch Mollusk Hermissenda crassicornis is an Agonist of Human α7 Nicotinic Acetylcholine Receptor

  2015cites this paper
• Molecular Interaction of α-Conotoxin RgIA with the Rat α9α10 Nicotinic Acetylcholine Receptor

  2015influential citation
• The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.

  2015cites this paper
• Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1

  2015cites this paper
• Conotoxins and Drug Discovery With Special Reference to Hainan Species

  2015cites this paper
• αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.

  2015cites this paper
• Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist

  2015cites this paper
• Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors

  2015cites this paper
• Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?

  2015cites this paper
• Pharmacologically Distinct Nicotinic Acetylcholine Receptors Drive Efferent-Mediated Excitation in Calyx-Bearing Vestibular Afferents

  2015influential citation
• Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors

  2015cites this paper
• Nicotinic receptors in non-human primates: analysis of genetic and functional conservation with humans

  2015cites this paper
• Alanine Scan of α-Conotoxin RegIIA Reveals a Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist*

  2014cites this paper
• Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.

  2014cites this paper
• Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain

  2014cites this paper
• Conotoxins Targeting Nicotinic Acetylcholine Receptors: An Overview

  2014cites this paper
• Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.

  2014cites this paper
• Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic pain.

  2014cites this paper
• Investigating epileptiform activity associated with slow wave sleep

  2014cites this paper
• Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain

  2014cites this paper
• Discovery, synthesis, and structure-activity relationships of conotoxins.

  2014cites this paper
• Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.

  2013cites this paper
• Neuronal nicotinic receptors as analgesic targets: it's a winding road.

  2013cites this paper
• Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

  2009cites this paper